PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$360.76
-9.40 (-2.54%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Price Target
Analyst Price Target
-94.6% upside
Low Target
$15.93
Average Target
$19.45
High Target
$25.00
Current Price
$360.76
Current
$360.76
$360.76
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Scenario Analysis
Bear Case
$15.93
-95.6%
Low target
Base Case
$19.45
-94.6%
Avg target
Bull Case
$25.00
+-93.1%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$382.54
-5.7% from high
52-Week Low
$37.19
+870.0% from low
50-Day SMA
$296.27
+21.8% vs SMA
200-Day SMA
$133.67
+169.9% vs SMA
RSI (14)
61.8
Neutral
Target vs 52W High
$19.45
-94.9% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-3.73
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |